Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals and clinics primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.

NYSE: PEN 135.35 -4.65 -3.32%
Volume: 357,574
Pricing delayed 20 minutes July 13, 2018 04:02 PM

SEC Filings

Date Filing Type Filing Description Download
Date July 13, 2018 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date July 10, 2018 Filing Type Form SC 13G/A Filing Description Amended Statement of Ownership Download

IR Contact


Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502